Company page

Biomark Diagnostics, Inc.

Biomark Diagnostics, Inc. (Ticker: BUX) is a public company based in Canada, specializing in innovative diagnostic solutions. With a market capitalization of approximately CAD 41.14 million, Biomark focuses on advancing healthcare through its proprietary technologies. The company aims to improve patient outcomes by providing accurate and timely diagnostic information.

BUX:CSEUpdated August 21, 2026
Biomark Diagnostics, Inc. logo
Ticker
BUX:CSE
Asset type
Stock
Market cap
$38.6M
Sector
Health Services
Industry
Medical/Nursing Services
Exchange
CSE
Currency
CAD